Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance

This publication has 58 references indexed in Scilit:

• Early follicular antimüllerian hormone as an indicator of ovarian reserve
  Fertility and Sterility, 2006
• Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B
  Fertility and Sterility, 2005
• Serum müllerian-inhibiting substance levels in adolescent girls with normal menstrual cycles or with polycystic ovary syndrome
  Fertility and Sterility, 2005
• Anti‐müllerian hormone as a marker of ovarian reserve*
  Australian and New Zealand Journal of Obstetrics and Gynaecology, 2005
• Metformin reduces serum müllerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
  Fertility and Sterility, 2005
• Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol
  Fertility and Sterility, 2004
• Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance
  The Journal of Steroid Biochemistry and Molecular Biology, 2004
• Serum müllerian-inhibiting substance levels during normal menstrual cycles
  Fertility and Sterility, 2000
• Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19
  Cytogenetic and Genome Research, 1987
• The Production of Mullerian Inhibiting Substance by the Fetal, Neonatal and Adult Rat1
  Biology of Reproduction, 1976